Biotricity Inc, a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is pleased to announce market expansion across five states nationwide, where it has commenced generating revenue. Bioflux was first launched with clients in Texas in the beginning of April this year and has since expanded into four additional states. The Company’s remote patient monitoring device Bioflux monitors a patient’s ECG in near real-time, constantly analyzing and collecting data on the device and periodically uploading to the cloud via embedded cellular technology.

“We are excited that we have secured anchor clients across multiple states in such a short period of time,” said Mr. Waqaas Al-Siddiq, Founder and CEO of Biotricity. “Our team’s innovation, drive, and dedication to our clients was critical to our growth and success this year.”

The Company is growing its presence in the connected-health market; an estimated 36 million patients are expected to be equipped with remote monitoring devices by 2020. With Bioflux, Biotricity believes doctors will have unprecedented levels of relevancy and timeliness to patient ECG information.

To learn more, visit www.biotricity.com.